NewsBenzingaJP Morgan inicia la cobertura de Definium Therapeutics con calificación de sobreponderar y anuncia un precio objetivo de 84 dólares JP Morgan inicia la cobertura de Definium Therapeutics con calificación de sobreponderar y anuncia un precio objetivo de 84 dólares Benzinga 2026.10.09 19:11 (GMT+0) Open on Benzinga Other news Billionaires Walk Away From Alphabet in Q3 - Hedge Funds Google ‘How to Sell’ and Hit Enter $100 Invested In Visa 15 Years Ago Would Be Worth This Much Today Western Digital Gains, Seagate Flat As Nvidia’s Raised Outlook Lifts AI Storage Hopes Home Depot Posts Strongest Comps In 4 Years, Analysts Revise Price Targets TJ Maxx Parent Bets on Accelerating Sales This Holiday Season Why Is Coinbase Stock Falling on Wednesday?